The Anti-VEGF Landscape: Recent Advances & New Prospects

Time: 9:30 am
day: Day One


  • Exploring how recently approved anti-VEGF drugs (Brolucizumab, Vabysmo, Susvimo) have focused on extending durability
  • Overviewing how several extended-release strategies are being developed
  • Elucidating combination therapy – Hopes of improving peak efficacy continues to be investigated but extending durability appears more achievable